8-K: Integer Holdings' Convertible Notes Become Exercisable Through Q3 2025 Following Strong Stock Performance

Integer Holdings Corporation announced that its 2.125% Convertible Senior Notes due 2028 are now convertible at the option of holders for the calendar quarter ending September 30, 2025, due to the company's common stock price exceeding the conversion threshold.

Summary

• Integer Holdings Corporation has notified holders of its 2.125% Convertible Senior Notes due 2028 that the notes are convertible at the option of the holders.
• The conversion period for these notes began on July 1, 2025, and will conclude at the close of business on September 30, 2025.
• The notes became convertible because the last reported sale price of Integer's common stock was greater than 130% of the conversion price for at least 20 trading days during the 30 consecutive trading days ending June 30, 2025.
• The conversion rate is set at 11.4681 shares of common stock per $1,000 principal amount of notes, which corresponds to an approximate conversion price of $87.20 per share.
• Integer Holdings Corporation retains the election to settle the conversion obligation in cash, up to the principal amount, and in cash, shares of common stock, or a combination thereof for any amount exceeding the aggregate principal amount of the notes being converted.

Sentiment

Score: 7

Explanation: The triggering of the convertible notes indicates strong stock performance, which is generally positive. However, the potential for dilution or cash outflow upon conversion introduces a degree of uncertainty regarding the capital structure.

Positives

• The company's common stock price has demonstrated strong performance, exceeding 130% of the conversion price for a sustained period, which triggered the convertibility of the notes.

Risks

• Potential for dilution of existing common stock if Integer Holdings Corporation elects to settle the conversion obligation in shares.
• Potential for cash outflow if Integer Holdings Corporation elects to settle the conversion obligation in cash.

Future Outlook

Any determination regarding the convertibility of the notes during future periods will be made in accordance with the terms of the Indenture governing the notes.

Management Comments

• "None of the Company, its Board of Directors or its employees has made or is making any representation or recommendation to any holder as to whether to exercise or refrain from exercising the Conversion Option."

Industry Context

Integer Holdings Corporation is a leading medical device contract development and manufacturing organization (CDMO) serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. This announcement pertains to its corporate financing strategy rather than specific industry trends or market conditions within the medical device sector.

Stakeholder Impact

• Shareholders: Potential for dilution if the company elects to settle the conversion obligation in shares.
• Note Holders: Have the option to convert their notes into cash, common stock, or a combination, depending on the company's election, potentially realizing gains if the stock price remains above the conversion price.

Next Steps

• Holders of the 2.125% Convertible Senior Notes due 2028 may exercise their conversion option during the calendar quarter ending September 30, 2025.
• Integer Holdings Corporation will determine the method of settlement (cash, shares, or a combination) for the conversion obligation.
• Future convertibility determinations will be made in accordance with the Indenture terms.

Key Dates

Keywords

Integer Holdings Corporation, ITGR, Convertible Senior Notes, Debt Conversion, Medical Device, CDMO, Corporate Finance, Capital Structure, NYSE